[HTML][HTML] Transdermal fentanyl: pharmacology and toxicology

L Nelson, R Schwaner - Journal of medical toxicology, 2009 - Springer
Objective To evaluate the underlying pharmacology safety, and misuse/abuse of
transdermal fentanyl, one of the cornerstone pharmacotherapies for patients with chronic …

Transdermal fentanyl: a review of its pharmacological properties and therapeutic efficacy in pain control

W Jeal, P Benfield - Drugs, 1997 - Springer
Fentanyl is a synthetic opioid with short-acting analgesic activity after intravenous or
subcutaneous administration. The low molecular weight, high potency and lipid solubility of …

[图书][B] Goodman & Gilman's the pharmacological basis of therapeutics

LL Brunton, BC Knollmann, R Hilal-Dandan - 2018 - researchgate.net
This book presents 55 clinical cases emphasizing the basic science aspects of pathology
and is “the closest you can get to the wards without seeing patients.” Each case includes an …

[PDF][PDF] Opioids, analgesia, and pain management

TL Yaksh, MS Wallace - … and Gilman's the pharmacological basis of …, 2011 - academia.edu
Tony L. Yaksh and Mark S. Wallace well-versed in the uses of opium; Arab traders
introduced the drug to the Orient, where it was employed mainly for the control of dysentery …

[图书][B] Karch's pathology of drug abuse

SB Karch, O Drummer - 2008 - taylorfrancis.com
Written for practitioners in the field, this critically acclaimed bestseller provides authoritative
information focused on the investigation of drug-related deaths and practical approaches to …

Protracted renal clearance of fentanyl in persons with opioid use disorder

AS Huhn, JG Hobelmann, GA Oyler… - Drug and alcohol …, 2020 - Elsevier
Introduction The illicit opioid supply in the US is increasingly adulterated with fentanyl. As
such, persons with opioid use disorder (OUD) may be regularly exposed to fentanyl …

Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl

S Grond, L Radbruch, KA Lehmann - Clinical pharmacokinetics, 2000 - Springer
Transdermal delivery allows continuous systemic application of opioids through the intact
skin. This review analyses the pharmacokinetic properties of transdermal opioid …

Fentanyl formulations in the management of pain: an update

SA Schug, S Ting - Drugs, 2017 - Springer
Fentanyl is a synthetic, highly selective opioid with many desirable physicochemical
properties, including a high lipophilicity and predictable pharmacokinetics. These properties …

Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control

RBR Muijsers, AJ Wagstaff - Drugs, 2001 - Springer
Fentanyl is a synthetic opioid agonist which interacts primarily with the μ-opioid receptor.
The low molecular weight, high potency and lipid solubility of fentanyl make it suitable for …

Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain

B Donner, M Zenz, M Tryba, M Strumpf - Pain, 1996 - Elsevier
Direct conversion from oral morphine to transdermal fentanyl with a ratio of oral
morphine/transdermal fentanyl (100: 1 mg) daily was examined in patients with cancer pain …